Cite
MLA Citation
Alexander M M Eggermont et al.. “Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.” Lancet oncology, vol. 16, no. 5, n.d., pp. 522–530. http://access.bl.uk/ark:/81055/vdc_100050846106.0x000028